Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR)
Latest Information Update: 21 Feb 2024
At a glance
- Drugs Edoxaban (Primary)
- Indications Embolism; Stroke
- Focus Therapeutic Use
- Acronyms ETAF-TR
- Sponsors Daiichi Sankyo Inc
- 30 Jun 2023 Status changed from active, no longer recruiting to completed.
- 18 May 2022 Planned End Date changed from 1 Dec 2022 to 1 May 2023.
- 18 May 2022 Planned primary completion date changed from 31 Jan 2022 to 1 May 2023.